Skip to content

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04545606
Acronym
RECHArge
Enrollment
180
Registered
2020-09-11
Start date
2020-09-15
Completion date
2030-08-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder, Insomnia Chronic

Keywords

cognitive behavioral therapy, behavioral therapy, children

Brief summary

Children with Autism Spectrum Disorder (ASD) and insomnia, and their parent(s) will undergo 4 sessions of behavioral therapy for sleep problems followed by 4 bimonthly booster sessions. Children and their families will be randomly assigned to one of three conditions: cognitive behavioral therapy (in-person), cognitive behavioral therapy (remote), or behavioral therapy (remote). Arousal will be measured through heart-rate variability. Sleep and secondary outcomes (child daytime behavior, parent sleep) will be collected at baseline (weeks 1-2 before starting the treatment), post-treatment (weeks 6-8 from baseline), 6-month follow-up, and 12-month follow-up.

Detailed description

Children with autism often have difficulties falling and staying asleep at night. Those sleep difficulties can contribute to daytime problems with irritability, learning, and behavior. Parents are often stressed about their child's sleep difficulties and as a result, their sleep can suffer as well. Treatment that focuses on establishing behaviors and routines that help reduce arousal and support good sleep are helpful for improving the sleep of children without autism, but have not yet been tested in children with autism. Previous studies have indicated that distance can make it difficult for families to participate in treatment. As such, we will conduct treatment remotely for two of treatment arms. Having remote versions of the treatment can expand the number of children and families that are able to receive these promising treatments. This may be particularly important for children with ASD living in rural and underserved areas as well as those in military families that may not have access to a healthcare provider with training in behavioral sleep treatments.

Interventions

BEHAVIORALIn-Person CBT for insomnia in children with autism

7 modules administered in-person 1. Sleep Hygiene & Sleep Prescription 2. Bedtime Routine & Parent Management 3. Cue Control & Parent Management 4. Co-Sleeping & Parents Fading out of Room 5. Circadian Education, Morning Routine, & Relaxation 6. Cognitive Therapy Basics 7. Nighttime Fears, Anxiety, & Nightmares

BEHAVIORALRemote CBT for insomnia in children with autism

7 modules administered over telehealth/videoconferencing 1. Sleep Hygiene & Sleep Prescription 2. Bedtime Routine & Parent Management 3. Cue Control & Parent Management 4. Co-Sleeping & Parents Fading out of Room 5. Circadian Education, Morning Routine, & Relaxation 6. Cognitive Therapy Basics 7. Nighttime Fears, Anxiety, & Nightmares

BEHAVIORALRemote sleep hygiene and related education (SHARE) for insomnia in children with autism

7 modules administered over telehealth/videoconferencing 1. Sleep Education 2. Sleep Architecture & Parasomnias 3. Physical Activity & Sleep 4. Nutrition, My Plate, & Breathing during Sleep 5. Stress, Sleep, Dreams, & Nightmares Connections 6. Mood, Self-Esteem, & Sleep 7. Light & Dark Cycle

Sponsors

United States Department of Defense
CollaboratorFED
University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 1\) 6-12a yrs * 2\) Verbal IQ \>= 70 * 3\) participation of child's parent or legal guardian living in the same home * 4\) parent/guardian ability to read and understand English at the 5th-grade level * 5\) child diagnosed with ASD and insomnia ASD: * 1\) previous DSM diagnosis of ASD * 2\) evaluation using gold-standard diagnostic tools (i.e., Autism Diagnostic Observation Schedule (ADOS) and/or Autism Diagnostic Interview-Revised \[ADI-R\]) Insomnia: * 1\) complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos * 2\) daytime dysfunction (mood, cognitive, social, academic) due to insomnia * 3\) baseline diaries and actigraphy indicate \>30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights

Exclusion criteria

* 1\) parent unable to provide informed consent or child unable to provide assent * 2\) unwilling to accept random assignment * 3\) participation in another randomized research project * 4\) parent unable to complete forms or implement treatment procedures due to cognitive impairment * 5\) untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias) * 6\) psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin as described in #7 (see Notes below for details) * 7\) stimulants, sleep medications (prescribed or OTC), and/or melatonin within the last 1 month (unless stabilized on medication for 3+ months) * 8\) participation in non-pharmacological treatment (including CBT) for sleep outside current trial * 9\) parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts) * 10\) other conditions adversely affecting trial participation

Design outcomes

Primary

MeasureTime frameDescription
Change in Average Objective Total Sleep Time for the parent from baseline to immediately after the intervention24/7 during each 2 week assessment immediately after the interventionActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Baseline Average Objective Sleep Efficiency for the child24/7 during each 2 week assessment at BaselineActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Change in Average Objective Sleep Efficiency for the child from baseline to immediately after the intervention24/7 during each 2 week assessment immediately after the interventionActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Change in Average Objective Sleep Efficiency for the child from baseline to 6 months24/7 during each 2 week assessment at 6 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Change in Average Objective Sleep Efficiency for the child from baseline to 12 months24/7 during each 2 week assessment at 12 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Baseline Average Bed/Waketime Variability for the child24/7 during each 2 week assessment at BaselineActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity and daily diary report
Change in Average Bed/Waketime Variability for the child from baseline to immediately after the intervention24/7 during each 2 week assessment immediately after the interventionActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity and daily diary report
Change in Average Bed/Waketime Variability for the child from baseline to 6 months24/7 during each 2 week assessment at 6 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity and daily diary report
Change in Average Bed/Waketime Variability for the child from baseline to 12 months24/7 during each 2 week assessment at 12 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity and daily diary report
Baseline Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child8 minute protocol during rest at Baseline (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Baseline Average Objective Total Sleep Time for the parent24/7 during each 2 week assessment at BaselineActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Change in Average Objective Total Sleep Time for the parent from baseline to 6 months24/7 during each 2 week assessment at 6 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity
Change in Average Objective Total Sleep Time for the parent from baseline to 12 months24/7 during each 2 week assessment at 12 month follow upActigraph (Actiwatch 2â, Philips Respironics) measures light and gross motor activity

Secondary

MeasureTime frameDescription
Baseline Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the childBaselineChild and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) includes 20 parent-reported items and is an appropriate outcome tool for children with ASD. It will be filled out by the parent in reference to the child.
Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child immediately after the interventionImmediately after the interventionChild and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) includes 20 parent-reported items and is an appropriate outcome tool for children with ASD. It will be filled out by the parent in reference to the child.
Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child at 6 monthsAt 6 month follow upChild and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) includes 20 parent-reported items and is an appropriate outcome tool for children with ASD. It will be filled out by the parent in reference to the child.
Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child at 12 monthsAt 12 month follow upChild and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) includes 20 parent-reported items and is an appropriate outcome tool for children with ASD. It will be filled out by the parent in reference to the child.
Baseline Child Quality of Life: PedsQL Child Form for the childBaselineChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the child in reference to the child.
Child Quality of Life: PedsQL Child Form for the child immediately after the interventionImmediately after the interventionChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the child in reference to the child.
Child Quality of Life: PedsQL Child Form for the child at 6 monthsAt 6 month follow upChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the child in reference to the child.
Child Quality of Life: PedsQL Child Form for the child at 12 monthsAt 12 month follow upChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the child in reference to the child.
Baseline Child Quality of Life: PedsQL Parent Form for the childBaselineChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the parent in reference to the child.
Child Quality of Life: PedsQL Parent Form for the child immediately after the interventionImmediately after the interventionChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the parent in reference to the child.
Child Quality of Life: PedsQL Parent Form for the child at 6 monthsAt 6 month follow upChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the parent in reference to the child.
Child Quality of Life: PedsQL Parent Form for the child at 12 monthsAt 12 month follow upChild Quality of Life: PedsQL is a 23-item scale measuring children's QOL. It has excellent internal consistency, clinical validity, and factor-analytic support. It will be filled out by the parent in reference to the child.
Baseline Average Subjective Sleep Onset Latency for the childEach morning for 2 weeks at BaselineDiary-reported amount of time from lights out to beginning of sleep filled out by the child (with parent help) regarding the child's sleep
Change in Average Subjective Sleep Onset Latency for the child from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported amount of time from lights out to beginning of sleep filled out by the child (with parent help) regarding the child's sleep
Change in Average Subjective Sleep Onset Latency for the child from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported amount of time from lights out to beginning of sleep filled out by the child (with parent help) regarding the child's sleep
Change in Average Subjective Sleep Onset Latency for the child from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported amount of time from lights out to beginning of sleep filled out by the child (with parent help) regarding the child's sleep
Baseline Average Subjective Total Wake Time for the childEach morning for 2 weeks at BaselineDiary-reported time awake from lights out until out of bed filled out by the child (with a parent's help) regarding the child's sleep
Change in Average Subjective Total Wake Time for the child from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported time awake from lights out until out of bed filled out by the child (with a parent's help) regarding the child's sleep
Change in Average Subjective Total Wake Time for the child from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported time awake from lights out until out of bed filled out by the child (with a parent's help) regarding the child's sleep
Change in Average Subjective Total Wake Time for the child from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported time awake from lights out until out of bed filled out by the child (with a parent's help) regarding the child's sleep
Baseline Average Subjective Total Sleep Time for the childEach morning for 2 weeks at BaselineDiary-reported total sleep time filled out by the child (with help of a parent) regarding the child's sleep
Change in Average Subjective Total Sleep Time for the child from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported total sleep time filled out by the child (with help of a parent) regarding the child's sleep
Change in Average Subjective Total Sleep Time for the child from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported total sleep time filled out by the child (with help of a parent) regarding the child's sleep
Change in Average Subjective Total Sleep Time for the child from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported total sleep time filled out by the child (with help of a parent) regarding the child's sleep
Baseline Average Subjective Sleep Efficiency for the childEach morning for 2 weeks at BaselineDiary-reported total sleep time/time in bed x 100% filled out by the child (with help from a parent) regarding the child's sleep
Change in Average Subjective Sleep Efficiency for the child from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported total sleep time/time in bed x 100% filled out by the child (with help from a parent) regarding the child's sleep
Change in Average Subjective Sleep Efficiency for the child from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported total sleep time/time in bed x 100% filled out by the child (with help from a parent) regarding the child's sleep
Change in Average Subjective Sleep Efficiency for the child from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported total sleep time/time in bed x 100% filled out by the child (with help from a parent) regarding the child's sleep
Baseline Average LF/HF ratio for the child8 minute protocol during rest at Baseline (in clinic)An index of the child's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the child from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)An index of the child's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the child from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)An index of the child's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the child from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)An index of the child's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Baseline Average pNN50 (% of N-N intervals > 50 ms) for the child8 minute protocol during rest at Baseline (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)Child arousal measured by Holter Monitors, 8 min ECG
Baseline Average LF/HF ratio for the parent8 minute protocol during rest at Baseline (in clinic)An index of the parent's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the parent from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)An index of the parent's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the parent from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)An index of the parent's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Change in Average LF/HF ratio for the parent from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)An index of the parent's autonomic nervous system regulation measured by Holter Monitors, 8 min ECG
Baseline Average pNN50 (% of N-N intervals > 50 ms) for the parent8 minute protocol during rest at Baseline (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Baseline Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent8 minute protocol during rest at Baseline (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to immediately after the intervention8 minute protocol during rest immediately after the intervention (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to 6 months8 minute protocol during rest at 6 month follow up (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to 12 months8 minute protocol during rest at 12 month follow up (in clinic)Parent arousal measured by Holter Monitors, 8 min ECG
Baseline State-Trait Anxiety Inventory (STAI-Y1) for the parentBaselineState-Trait Anxiety Inventory (STAI-Y1) includes 20 self-descriptive statements rated according to how the parent generally feels on a 4-point scale \[1 (not at all) to 4 (very much so)\]. This will be filled out by the parents regarding the parents.
State-Trait Anxiety Inventory (STAI-Y1) for the parent immediately after the interventionImmediately after the interventionState-Trait Anxiety Inventory (STAI-Y1) includes 20 self-descriptive statements rated according to how the parent generally feels on a 4-point scale \[1 (not at all) to 4 (very much so)\]. This will be filled out by the parents regarding the parents.
State-Trait Anxiety Inventory (STAI-Y1) for the parent at 6 monthsAt 6 month follow upState-Trait Anxiety Inventory (STAI-Y1) includes 20 self-descriptive statements rated according to how the parent generally feels on a 4-point scale \[1 (not at all) to 4 (very much so)\]. This will be filled out by the parents regarding the parents.
State-Trait Anxiety Inventory (STAI-Y1) for the parent at 12 monthsAt 12 month follow upState-Trait Anxiety Inventory (STAI-Y1) includes 20 self-descriptive statements rated according to how the parent generally feels on a 4-point scale \[1 (not at all) to 4 (very much so)\]. This will be filled out by the parents regarding the parents.
Baseline Beck Depression Inventory (BDI-II) for the parentBaselineBeck Depression Inventory (BDI-II) includes 21 items that measures the severity of depressive symptomatology on a 4-point scale (0-absence of symptoms; 3-severe). This will be filled out by the parents regarding the parents.
Beck Depression Inventory (BDI-II) for the parent immediately after the interventionImmediately after the interventionBeck Depression Inventory (BDI-II) includes 21 items that measures the severity of depressive symptomatology on a 4-point scale (0-absence of symptoms; 3-severe). This will be filled out by the parents regarding the parents.
Beck Depression Inventory (BDI-II) for the parent at 6 monthsAt 6 month follow upBeck Depression Inventory (BDI-II) includes 21 items that measures the severity of depressive symptomatology on a 4-point scale (0-absence of symptoms; 3-severe). This will be filled out by the parents regarding the parents.
Beck Depression Inventory (BDI-II) for the parent at 12 monthsAt 12 month follow upBeck Depression Inventory (BDI-II) includes 21 items that measures the severity of depressive symptomatology on a 4-point scale (0-absence of symptoms; 3-severe). This will be filled out by the parents regarding the parents.
Baseline Aberrant Behavior Checklist (ABC) for the childBaselineAberrant Behavior Checklist (ABC) is a 58-item parent-report measure of daytime problem behaviors that is psychometrically strong and sensitive to treatment effects in children with ASD. It will be filled out by the parent in reference to the child.
Fatigue Severity Scale for the parent immediately after the interventionImmediately after the interventionFatigue Severity Scale includes 9 items on the severity of fatigue and how fatigue interferes with activities on a 7-point scale (1-strongly disagree; 7-strongly agree). This will be filled out by the parents regarding the parents.
Fatigue Severity Scale for the parent at 6 monthsAt 6 month follow upFatigue Severity Scale includes 9 items on the severity of fatigue and how fatigue interferes with activities on a 7-point scale (1-strongly disagree; 7-strongly agree). This will be filled out by the parents regarding the parents.
Fatigue Severity Scale for the parent at 12 monthsAt 12 month follow upFatigue Severity Scale includes 9 items on the severity of fatigue and how fatigue interferes with activities on a 7-point scale (1-strongly disagree; 7-strongly agree). This will be filled out by the parents regarding the parents.
Baseline Daily Fatigue for the parentBaselineDaily Fatigue rated on electronic diaries (0-none;100-most intense imaginable). This will be filled out by the parents regarding the parents.
Daily Fatigue for the parent immediately after the interventionImmediately after the interventionDaily Fatigue rated on electronic diaries (0-none;100-most intense imaginable). This will be filled out by the parents regarding the parents.
Daily Fatigue for the parent at 6 monthsAt 6 month follow upDaily Fatigue rated on electronic diaries (0-none;100-most intense imaginable). This will be filled out by the parents regarding the parents.
Daily Fatigue for the parent at 12 monthsAt 12 month follow upDaily Fatigue rated on electronic diaries (0-none;100-most intense imaginable). This will be filled out by the parents regarding the parents.
Baseline Caregiver Strain Index (CSI) for the parentBaselineCaregiver Strain Index (CSI) includes 12 items on caregiving impact on well-being. This will be filled out by the parents regarding the parents.
Caregiver Strain Index (CSI) for the parent immediately after the interventionImmediately after the interventionCaregiver Strain Index (CSI) includes 12 items on caregiving impact on well-being. This will be filled out by the parents regarding the parents.
Caregiver Strain Index (CSI) for the parent at 6 monthsAt 6 month follow upCaregiver Strain Index (CSI) includes 12 items on caregiving impact on well-being. This will be filled out by the parents regarding the parents.
Caregiver Strain Index (CSI) for the parent at 12 monthsAt 12 month follow upCaregiver Strain Index (CSI) includes 12 items on caregiving impact on well-being. This will be filled out by the parents regarding the parents.
Baseline Average Subjective Sleep Onset Latency for the parentEach morning for 2 weeks at BaselineDiary-reported amount of time from lights out to beginning of sleep filled out by the parent regarding parent sleep
Change in Average Subjective Sleep Onset Latency for the parent from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported amount of time from lights out to beginning of sleep filled out by the parent regarding parent sleep
Change in Average Subjective Sleep Onset Latency for the parent from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported amount of time from lights out to beginning of sleep filled out by the parent regarding parent sleep
Change in Average Subjective Sleep Onset Latency for the parent from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported amount of time from lights out to beginning of sleep filled out by the parent regarding parent sleep
Baseline Average Subjective Total Wake Time for the parentEach morning for 2 weeks at BaselineDiary-reported time awake from lights out until out of bed filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Wake Time for the parent from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported time awake from lights out until out of bed filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Wake Time for the parent from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported time awake from lights out until out of bed filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Wake Time for the parent from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported time awake from lights out until out of bed filled out by the parent regarding the parent's sleep
Baseline Average Subjective Total Sleep Time for the parentEach morning for 2 weeks at BaselineDiary-reported total sleep time filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Sleep Time for the parent from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported total sleep time filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Sleep Time for the parent from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported total sleep time filled out by the parent regarding the parent's sleep
Change in Average Subjective Total Sleep Time for the parent from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported total sleep time filled out by the parent regarding the parent's sleep
Baseline Average Subjective Sleep Efficiency for the parentEach morning for 2 weeks at BaselineDiary-reported total sleep time/time in bed x 100% filled out by the parent regarding the parent's sleep
Change in Average Subjective Sleep Efficiency for the parent from baseline to immediately after the interventionEach morning for 2 weeks immediately after the interventionDiary-reported total sleep time/time in bed x 100% filled out by the parent regarding the parent's sleep
Change in Average Subjective Sleep Efficiency for the parent from baseline to 6 monthsEach morning for 2 weeks at 6 month follow upDiary-reported total sleep time/time in bed x 100% filled out by the parent regarding the parent's sleep
Change in Average Subjective Sleep Efficiency for the parent from baseline to 12 monthsEach morning for 2 weeks at 12 month follow upDiary-reported total sleep time/time in bed x 100% filled out by the parent regarding the parent's sleep
Baseline Fatigue Severity Scale for the parentBaselineFatigue Severity Scale includes 9 items on the severity of fatigue and how fatigue interferes with activities on a 7-point scale (1-strongly disagree; 7-strongly agree). This will be filled out by the parents regarding the parents.
Aberrant Behavior Checklist (ABC) for the child immediately after the interventionImmediately after the interventionAberrant Behavior Checklist (ABC) is a 58-item parent-report measure of daytime problem behaviors that is psychometrically strong and sensitive to treatment effects in children with ASD. It will be filled out by the parent in reference to the child.
Aberrant Behavior Checklist (ABC) for the child at 6 monthsAt 6 month follow upAberrant Behavior Checklist (ABC) is a 58-item parent-report measure of daytime problem behaviors that is psychometrically strong and sensitive to treatment effects in children with ASD. It will be filled out by the parent in reference to the child.
Aberrant Behavior Checklist (ABC) for the child at 12 monthsAt 12 month follow upAberrant Behavior Checklist (ABC) is a 58-item parent-report measure of daytime problem behaviors that is psychometrically strong and sensitive to treatment effects in children with ASD. It will be filled out by the parent in reference to the child.
Baseline Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+)BaselineConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) immediately after the interventionImmediately after the interventionConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) at 6 monthsAt 6 month follow upConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) at 12 monthsAt 12 month follow upConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Baseline Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7)BaselineConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) immediately after the interventionImmediately after the interventionConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) at 6 monthsAt 6 month follow upConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) at 12 monthsAt 12 month follow upConners' Continuous Performance Test - 3rd Edition (CCPT-3) is a computerized measure of inattentiveness, impulsivity, sustained attention, and vigilance for aged 8 and above. Conners' Kiddie Continuous Performance Test (K-CPT) will be used for children aged 6 and 7 which provides a comparable measure of the four domains of attention. To account for two different measures in analyses, standardized scores will be used.
Baseline Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the childBaselineBehavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) is a 86-item parent-report measure of day-to-day executive functioning and impairment. It will be filled out by the parent in reference to the child.
Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child immediately after the interventionImmediately after the interventionBehavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) is a 86-item parent-report measure of day-to-day executive functioning and impairment. It will be filled out by the parent in reference to the child.
Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child at 6 monthsAt 6 month follow upBehavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) is a 86-item parent-report measure of day-to-day executive functioning and impairment. It will be filled out by the parent in reference to the child.
Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child at 12 monthsAt 12 month follow upBehavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) is a 86-item parent-report measure of day-to-day executive functioning and impairment. It will be filled out by the parent in reference to the child.

Countries

United States

Contacts

Primary ContactMelanie Stearns, PhD
mastearns@health.missouri.edu859-327-7762
Backup ContactSydney Shoemaker, MS
sds3mk@health.missouri.edu573-882-5113

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026